Keyphrases
Hereditary Angioedema
100%
Patient Survey
100%
C1 Esterase Inhibitor
38%
Disease Burden
14%
On-demand Treatment
9%
Chronic Disease
4%
United States
4%
High Burden
4%
Patient Perspective
4%
Treatment Options
4%
Emergency Department
4%
Patient Characteristics
4%
One Session
4%
Novel Therapies
4%
Quality of Life Impact
4%
Prophylactic Treatment
4%
Survey Questions
4%
Treatment Burden
4%
Angioedema Attack
4%
Educational Initiatives
4%
Individual Treatment Plan
4%
Icatibant
4%
Audience Response System
4%
Ecallantide
4%
Medicine and Dentistry
Hereditary Angioedema
100%
Complement Component C1s Inhibitor
38%
Disease
14%
Quality of Life
4%
Emergency Department
4%
Patient Characteristics
4%
Prophylaxis
4%
Chronic Disease
4%
Angioedema
4%
Ecallantide
4%
Icatibant
4%
Biochemistry, Genetics and Molecular Biology
Hereditary Angioedema
100%
C1-Inhibitor
40%
Disease Burden
15%
Angioedema
5%
Ecallantide
5%
Icatibant
5%
Pharmacology, Toxicology and Pharmaceutical Science
Angioneurotic Edema
100%
Complement Component C1s Inhibitor
38%
Disease
14%
Chronic Disease
4%
Icatibant
4%
Ecallantide
4%